CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment (Q33419302)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment |
scientific article |
Statements
1 reference
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment (English)
1 reference
Susan Domchek
1 reference
Angela DeMichele
1 reference
Amy S Clark
1 reference
Kay See Tan
1 reference
Daniel F Heitjan
1 reference
Kristi Gramlich
1 reference
Maryann Gallagher
1 reference
Priti Lal
1 reference
Michael Feldman
1 reference
Paul Zhang
1 reference
Christopher Colameco
1 reference
David Lewis
1 reference
Melissa Langer
1 reference
Noah Goodman
1 reference
Keerthi Gogineni
1 reference
Mark Rosen
1 reference
Kevin Fox
1 reference
Peter O'Dwyer
1 reference
11 December 2014
1 reference
1 reference
21
1 reference
995-1001
1 reference
Identifiers
1 reference
1 reference